40 results
8-K
EX-3.1
AUPH
Aurinia Pharmaceuticals Inc.
12 Sep 24
Aurinia Announces Board Restructuring
4:08pm
and duties of all other officers shall, subject to the Act, be such as the terms of their engagement call for or as the Board or, (except for those … lien upon all the shares registered in the name of such shareholder whether solely or jointly with others for his debts, liabilities and engagement
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc.
3 Jun 24
Additional proxy soliciting materials
6:28pm
, such that his or her employment or engagement has been frustrated. For purposes of Incentive Stock Options, “Disability” shall mean a “permanent and total
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc.
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
barriers to care among LN patients, (Diversity, Equity and Inclusion) DE&I practices, employee engagement, and risk management. The full report is available
DEFA14A
39wvundjwwuvposfk
18 Apr 22
Additional proxy soliciting materials
7:36am
S-8
EX-10.1
c617836x676o mcm
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.1
88dc1da4
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
1lqj0rwg uktx9j5
10 May 21
Definitive proxy
4:06pm
PRE 14A
mw18taej
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-3.2
sekh3qq69dp 1hos
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
10-K
EX-10.17
cd5o2qz
24 Feb 21
Annual report
4:09pm
8-K
EX-99.2
evae37h73ebq67bir 39
25 Jan 21
Financial Statements and Exhibits
8:21am
8-K
EX-99.1
hlelc3
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
EX-99.2
5udk9bl1w59r
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
lszjsietav
14 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
6:10am